<?xml version="1.0" encoding="UTF-8"?>
<ref id="B89">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>X. H.</given-names>
   </name>
   <name>
    <surname>Flores</surname>
    <given-names>L. M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Krop</surname>
    <given-names>I. E.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2010</year>). 
  <article-title>Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.</article-title>
  <source>
   <italic>Cancer Res.</italic>
  </source>
  <volume>70</volume>
  <fpage>2256</fpage>â€“
  <lpage>2263</lpage>. 
  <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-4032</pub-id>
  <?supplied-pmid 20197472?>
  <pub-id pub-id-type="pmid">20197472</pub-id>
 </mixed-citation>
</ref>
